Amanote Research
Register
Sign In
Suppression of Dendritic Cells by IL10 Limits Chemotherapy Responses
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2014-223
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 30, 2014
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Toso Controls Encephalitogenic Immune Responses by Dendritic Cells and Regulatory T Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Suppression of Antigen-Specific Adaptive Immunity by IL-37 via Induction of Tolerogenic Dendritic Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/Il10 Axis
Frontiers in Immunology
Allergy
Immunology
Suppression of Macrophage Inflammatory Responses by PPARs
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Concanavalin A-Induced T Cell Responses Mediated by Allogeneic Dendritic Cells in Humans.
Japanese Journal of Clinical Immunology
Cross-Talks of Tumor and Myeloid Cells Regulate the Therapeutic Responses to Chemotherapy by Modulating Innate Immune Responses
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells
Journal of Immunology
Allergy
Immunology
Vaccination With Dendritic Cells Transfected With BAK and BAX siRNA Enhances Antigen-Specific Immune Responses by Prolonging Dendritic Cell Life
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Clinical Adjuvant Combinations Stimulate Potent B-Cell Responses in Vitro by Activating Dermal Dendritic Cells
PLoS ONE
Multidisciplinary
